About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Moot Cost-Effective Strategy to Screen Second Primary Colorectal Cancers

by Rajashri on July 18, 2009 at 8:36 PM
Font : A-A+

 Researchers Moot Cost-Effective Strategy to Screen Second Primary Colorectal Cancers

A research group has constructed a decision-analytic model and compared cost-effectiveness results of cancer screening in male cancer survivors in a bid to suggest a feasible economic strategy for second primary colorectal cancer screening of cancer survivors in Korea.

All non-dominant strategies were those using colonoscopy in both cancer survivors and the general population, and more strict and frequent recommendation of colonoscopy, colonoscopy every 5 years and every 3 years, could be considered as economic strategies for male cancer survivors.

Advertisement

The recent improvement in cancer survival due to early diagnosis and advances in treatment has raised the issue of second primary cancers in cancer survivors after their primary treatment. The age-standardized incidence rate was about 4 times higher for second primary colorectal cancer (CRC) than for first primary CRC in Korea. However, until now, there have been few recommendations and economic evaluations of CRC screening for cancer survivors.

A research article to be published in the World Journal of Gastroenterology on July 7,2009 addresses this question To suggest a feasible economic strategy of second CRC screening for cancer survivors in Korea, authors constructed a decision-analytic model, and compared the cost-effectiveness results of cancer screening in male cancer survivors.
Advertisement

All non-dominated strategies were those using colonoscopy in both cancer survivors and the general population, and more strict and frequent recommendation of colonoscopy such as COL5 (screening every 5 years) and COL3 (screening every 3 years) could be considered as economic strategies for male cancer survivors.

The major barrier to promoting colonoscopy as a primary CRC screening tool is the lack of manpower to deliver colonoscopy to the public in Korea. In these human-resource limited settings, it is important to identify the most vulnerable population who has the most potential to receive the benefits. In younger cancer survivors aged 40 years old, COL5 might be economically feasible, while COL10 is usually recommended for the Korean general population aged 50 years old. Therefore, at least for cancer survivors, CRC screening should be covered by the Korean national health insurance scheme and screening methods using colonoscopy should be recommended as a primary screening strategy for CRC in this population.



Source: Eurekalert
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Colorectal Cancer Cancer 

Recommended Reading
Colo-rectal cancer - Management
Treatment for Colorectal Cancers may involve surgery,chemotherapy, radiation therapy or biological ....
Colonoscopy Procedure - Animation
An animation of Colonoscopy that shows the appearance of large intestine or colon by using a thin .....
Volvulus - Animation
A volvulus is surgical condition that results in a loop of the bowel twisting on itself. This can .....
Colorectal Cancer
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancer is the third...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use